Combined effect of ALK and MEK inhibitors in EML4-ALK-positive non-small-cell lung cancer cells.
Tanizaki J; Okamoto I; Takezawa K; Sakai K; Azuma K; Kuwata K; Yamaguchi H; Hatashita E; Nishio K; Janne PA; Nakagawa K; British Journal Of Cancer, 2012, vol. 106, issue 4, p 763, ISSN 15321827. ISBN 15321827.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef